Paranovus Entertainment Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Paranovus Entertainment Technology şirketinin toplam hissedar öz sermayesi $5.2M ve toplam borcu $2.3M olup, bu da borç-öz sermaye oranını 44.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $7.7M ve $2.6M dir.

Anahtar bilgiler

44.3%

Borç/özkaynak oranı

US$2.29m

Borç

Faiz karşılama oranı	n/a
Nakit	US$944.24k
Eşitlik	US$5.17m
Toplam yükümlülükler	US$2.56m
Toplam varlıklar	US$7.73m

Son finansal sağlık güncellemeleri

Recent updates

Take Care Before Jumping Onto Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Even Though It's 26% Cheaper

Mar 20

Here's What To Make Of Happiness Biotech Group's (NASDAQ:HAPP) Returns On Capital

Jan 24

Happiness Biotech stock surge as its e-commerce business grew over 70% M/M in December

Jan 11

Happiness Biotech rallies on subsidiary receiving policy granting 80% tax rebates from local government

Dec 16

Would Shareholders Who Purchased Happiness Biotech Group's (NASDAQ:HAPP) Stock Year Be Happy With The Share price Today?

Nov 24

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PAVS 'nin kısa vadeli varlıkları ( $2.9M ) kısa vadeli yükümlülüklerini ( $2.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: PAVS un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PAVS 'nin net borç/öz sermaye oranı ( 26% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: PAVS şirketinin borç/öz sermaye oranı son 5 yılda 1.7% seviyesinden 44.3% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: PAVS şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: PAVS un, serbest nakit akışı her yıl % 53.1 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Paranovus Entertainment Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Paranovus Entertainment Technology Ltd. announced delayed 20-F filing

Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Happiness Development Group Limited announced delayed 20-F filing

Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Recent updates

High number of new and inexperienced directors

Paranovus Entertainment Technology Ltd. announced delayed 20-F filing

New minor risk - Financial data availability

High number of new and inexperienced directors

High number of new and inexperienced directors

New major risk - Market cap size

Take Care Before Jumping Onto Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Even Though It's 26% Cheaper

First half 2024 earnings released: EPS: US$2.06 (vs US$0.053 loss in 1H 2023)

Sentiment Still Eluding Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS)

Paranovus Entertainment Technology Ltd. (NasdaqCM:PAVS) entered into a non-binding letter of intent to acquire 100% of Blueline Studios Inc. from Caravan Digital L.P.

Paranovus Entertainment Technology Ltd. (NasdaqCM:PAVS) entered into a non-binding letter of intent to acquire 100% of Blueline Studios Inc. from Caravan Digital L.P.

Full year 2023 earnings released: US$253 loss per share (vs US$24.30 loss in FY 2022)

New major risk - Share price stability

Paranovus Entertainment Technology Ltd., Annual General Meeting, Jun 30, 2023

First half 2023 earnings released: US$9.57 loss per share (vs US$0.37 loss in 1H 2022)

An unknown buyer agreed to acquire 70% stake in Happy Automobile Service (Nanping) Co., Ltd. from Happy Automobile Service (Nanping) Co., Ltd. for CNY 1.4446 million.

Happiness Development Group Limited Announces Chief Financial Officer Changes

First half 2023 earnings released: US$9.57 loss per share (vs US$0.37 loss in 1H 2022)

Happiness Development Group Limited Announces Board Changes

Happiness Development Group Limited Announces Board and Committee Changes

High number of new directors

Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Happiness Development Group announces 1-for-20 reverse stock split

Happiness Development Group Limited announced delayed 20-F filing

Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Less than half of directors are independent

Happiness Development Group Limited announced that it expects to receive $10 million in funding

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Happiness Biotech Launches Lucidum Tablets on Douyin Mall

Full year 2021 earnings released: EPS US$0.03 (vs US$0.53 in FY 2020)

Happiness Biotech Group (NASDAQ:HAPP) Could Be Struggling To Allocate Capital

Happiness Biotech inks EV distribution agreement with Geely's subsidiary

A Look At Happiness Biotech Group's (NASDAQ:HAPP) Share Price Returns

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$2.40

Happiness Biotech Group Limited Launches Auto Sales Platform "Happy Auto"

First half 2021 earnings released: EPS US$0.13

Here's What To Make Of Happiness Biotech Group's (NASDAQ:HAPP) Returns On Capital

Investor sentiment improved over the past week

New 90-day high: US$2.12

Happiness Biotech stock surge as its e-commerce business grew over 70% M/M in December

Happiness Biotech rallies on subsidiary receiving policy granting 80% tax rebates from local government

Would Shareholders Who Purchased Happiness Biotech Group's (NASDAQ:HAPP) Stock Year Be Happy With The Share price Today?

Happiness Biotech Group Limited Approves Appointment of Wenhui Lin as Director

Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores

New 90-day low: US$1.68

New 90-day low: US$1.93

New 90-day low - US$2.25

New 90-day low - US$2.35

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin